Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Rima Kaddurah-Daouk, PhD
Metabolomic Signatures of Preclinical and Early Alzheimer's Disease: Discovery of Novel Biomarkers for Drug and Disease Monitoring
A GuideStar-Rated Charity
© Copyright 2025. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).